Mostrar el registro sencillo del ítem

Artículo

dc.creatorSanegre, Sabinaes
dc.creatorLucantoni, Federicoes
dc.creatorBurgos-Panadero, Rebecaes
dc.creatorCruz Merino, Luis de laes
dc.creatorNoguera, Rosaes
dc.creatorNaranjo, Tomás Álvaroes
dc.date.accessioned2023-06-12T11:40:16Z
dc.date.available2023-06-12T11:40:16Z
dc.date.issued2020
dc.identifier.citationSanegre, S., Lucantoni, F., Burgos-Panadero, R., Cruz Merino, L.d.l., Noguera, R. y Naranjo, T.Á. (2020). Integrating the tumor microenvironment into cancer therapy. Cancers, 12 (6), 1677. https://doi.org/10.3390/cancers12061677.
dc.identifier.issn2072-6694es
dc.identifier.urihttps://hdl.handle.net/11441/147081
dc.description.abstractTumor progression is mediated by reciprocal interaction between tumor cells and their surrounding tumor microenvironment (TME), which among other factors encompasses the extracellular milieu, immune cells, fibroblasts, and the vascular system. However, the complexity of cancer goes beyond the local interaction of tumor cells with their microenvironment. We are on the path to understanding cancer from a systemic viewpoint where the host macroenvironment also plays a crucial role in determining tumor progression. Indeed, growing evidence is emerging on the impact of the gut microbiota, metabolism, biomechanics, and the neuroimmunological axis on cancer. Thus, external factors capable of influencing the entire body system, such as emotional stress, surgery, or psychosocial factors, must be taken into consideration for enhanced management and treatment of cancer patients. In this article, we review prognostic and predictive biomarkers, as well as their potential evaluation and quantitative analysis. Our overarching aim is to open up new fields of study and intervention possibilities, within the framework of an integral vision of cancer as a functional tissue with the capacity to respond to different non-cytotoxic factors, hormonal, immunological, and mechanical forces, and others inducing stroma and tumor reprogramming.es
dc.formatapplication/pdfes
dc.format.extent22 pág.es
dc.language.isoenges
dc.publisherMDPIes
dc.relation.ispartofCancers, 12 (6), 1677.
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectBiomarker discoveryes
dc.subjectImmune therapyes
dc.subjectMechanotransductiones
dc.subjectMetabolismes
dc.subjectMetformines
dc.subjectMicrobiotaes
dc.subjectMitochondriaes
dc.subjectPrognostic toolses
dc.subjectStromal reprogramminges
dc.subjectVitamin D3es
dc.titleIntegrating the tumor microenvironment into cancer therapyes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Bioquímica Médica y Biología Molecular e Inmunologíaes
dc.relation.projectIDCB16/12/00484es
dc.relation.projectIDPI17/01558es
dc.relation.projectIDFAECC2015/006es
dc.relation.projectID2017-PVR00157es
dc.relation.publisherversionhttps://www.mdpi.com/2072-6694/12/6/1677es
dc.identifier.doi10.3390/cancers12061677es
dc.journaltitleCancerses
dc.publication.volumen12es
dc.publication.issue6es
dc.publication.initialPage1677es
dc.contributor.funderCIBERONCes
dc.contributor.funderFEDER (European Regional Development Fund)es
dc.contributor.funderFundacion Cientifica de la Asociacion Espanola contra el Canceres
dc.contributor.funderISCIII (FIS)es
dc.contributor.funderNEN Association (Nico contra el cancer infantil)es

FicherosTamañoFormatoVerDescripción
Integrating the tumor microenv ...6.627MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Atribución 4.0 Internacional